MedTrace Logo

In-vivo Efficacy Study of Patient Preoperative Preps

NCT01968356 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2024-10-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Conditions

  • Skin Flora Bacterial Reduction Post-product Application

Interventions

DRUG

3M CHG/IPA Prep Colorless

Apply topically.

DRUG

3M CHG/IPA Prep Tint

Apply topically.

DRUG

ChloraPrep

Apply topically.

DRUG

Saline

Apply topically.

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Robert R McCormack, BS · BioScience Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01968356 on ClinicalTrials.gov